AROMATASE INHIBITORS - EVALUATION OF MAMMARY-TUMOR INHIBITING NON-STEROIDAL COMPOUNDS

被引：0
|
作者：
BATZL, C [1 ]
SCHWARZ, W [1 ]
HARTMANN, RW [1 ]
机构：
[1] UNIV REGENSBURG,INST PHARM,D-8400 REGENSBURG,FED REP GER
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1985年 / 109卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [31] A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer
    Beresford, M.
    Tumur, I.
    Chakrabarti, J.
    Barden, J.
    Rao, N.
    Makris, A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : 209 - 215
  • [32] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    Chin, Y. S.
    Beresford, M. J.
    Ravichandran, D.
    Makris, A.
    BREAST, 2007, 16 (04): : 436 - 439
  • [33] TETRAMETHYLHES - A NEW MAMMARY-TUMOR INHIBITING ANTIESTROGEN (AE) - EVALUATION AND STUDIES ON THE MODE OF ACTION
    HARTMANN, RW
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 126 - 126
  • [34] 2- and 3-[(Aryl)(azolyl)methyl]indoles as Potential Non-steroidal Aromatase Inhibitors
    Lézé, MP
    Le Borgne, M
    Marchand, P
    Loquet, D
    Kogler, M
    Le Baut, G
    Palusczak, A
    Hartmann, RW
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (06) : 549 - 557
  • [35] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 167 - 167
  • [36] Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1
    Camilla Fusi
    Serena Materazzi
    Silvia Benemei
    Elisabetta Coppi
    Gabriela Trevisan
    Ilaria M. Marone
    Daiana Minocci
    Francesco De Logu
    Tiziano Tuccinardi
    Maria Rosaria Di Tommaso
    Tommaso Susini
    Gloriano Moneti
    Giuseppe Pieraccini
    Pierangelo Geppetti
    Romina Nassini
    Nature Communications, 5
  • [37] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Nazli Bahrami
    Shakila Jabeen
    Andliena Tahiri
    Torill Sauer
    Hilde Presterud Ødegård
    Stephanie Beate Geisler
    Berit Gravdehaug
    Laurens Cornelus Reitsma
    Knut Selsås
    Vessela Kristensen
    Jürgen Geisler
    Breast Cancer Research and Treatment, 2021, 190 : 435 - 449
  • [38] Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors
    Dai, Yujie
    Wang, Qiang
    Zhang, Xiuli
    Jia, Shiru
    Zheng, Heng
    Feng, Dacheng
    Yu, Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (12) : 5612 - 5620
  • [39] A QUALITATIVE SYSTEMATIC REVIEW OF THE EVIDENCE BASE FOR NON CROSS-RESISTANCE BETWEEN STEROIDAL AND NON-STEROIDAL AROMATASE INHIBITORS (AIS) IN METASTATIC BREAST CANCER
    Chakrabarti, J.
    Beresford, M.
    Tumur, I.
    Barden, J.
    Rao, N.
    Makris, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 107 - 107
  • [40] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Bahrami, Nazli
    Jabeen, Shakila
    Tahiri, Andliena
    Sauer, Torill
    Odegard, Hilde Presterud
    Geisler, Stephanie Beate
    Gravdehaug, Berit
    Reitsma, Laurens Cornelus
    Selsas, Knut
    Kristensen, Vessela
    Geisler, Jurgen
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (03) : 435 - 449
12345